January 21, 2025

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

NRG Oncology would like to thank our attendees for joining us in Phoenix for an eventful and engaging NRG Meeting! We would also like to thank those who joined us virtually for our online sessions. Please check the NRG Oncology Meeting Webpages in the coming days for session presentation slide postings as they become available.

We hope that you join us for our Summer Meeting, NRG2025 in Washington DC - July 24-26, 2025.

ACTIVATION

GYNECOLOGIC

NRG-GY036: Activated January 16, 2025; version date: December 31, 2024 (posted on CTSU)

AMENDMENTS

BREAST

NRG-BR008/HERO: Amendment 1; January 21, 2025 (posted on CTSU)

CANCER PREVENTION & CONTROL

NRG-CC005/FORTE: Amendment 7; version date: January 21, 2025 (posted on CTSU) 

FORM UPDATES

BRAIN

NRG-BN013: The Eligibility Checklist has been updated. Please begin using the new checklist immediately. The revised checklist has been posted on CTSU. 

LUNG

NRG-LU008: Please continue to use PRO-CTCAE (Version 1.0) posted on CTSU on May 10, 2023 until further notice.

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More

2. BIOSPECIMEN BANKS

Printing Biospecimen Transmittal PDFs from Rave

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

3. BREAST

NRG-BR008/HERO: Updated Pathology Instructions; January 17, 2025 (posted on CTSU) 

4. CANCER PREVENTION & CONTROL

NRG-CC005/FORTE: Updated Pathology Instructions, January 17, 2025 (posted on CTSU) 

NRG-CC010: The study is open to NRG sites in Japan and South Korea. The optional biospecimen collection does not apply to sites participating in these countries.

5. GYNECOLOGIC

NRG-GY026: Please note, the post-chemo cfDNA Whole Blood (WB03) should only be collected if the Pre-Treatment cfDNA Whole Blood (WB01) was collected.

NRG-GY031: Please note, there is an error in the section 4.2 table and the Biospecimen Collection and Submission Manual. The Part I PK collection is to be done on Cycle 1, Day 1, and Cycle 1, Day 8. This will be updated with the next amendment.

6. HEAD & NECK

NRG-HN008

Reminder: please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important.

NRG-HN010: The Spanish-translated consent forms for Amendment 3 and CIRB approval of the forms are available on CTSU.

7. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, NRG-BR009, NRG-BN014, NRG-CC011, NRG-CC013, NRG-HN014, and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for February 12, 2025.

Investigator’s Brochure (IB*) updates have been issued for the following studies:

*The current version of the Investigator Brochure Documents for Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI)-sponsored trials are available for access via the Cancer Therapy Evaluation Program (CTEP) Agent Inventory Management System (AURORA) application. Log-in using your Identity and Access Management (IAM) or ID.me credentials and provide the requested information to access the document.

Every site principal investigator is responsible for reviewing this document. The Investigator Brochure is for use by the site principal investigator and any study personnel under his/her supervision who need to know the contents for the conduct of a clinical trial, including Institutional Review Board(s) or Independent Ethics Committee(s).

1. The NRG Oncology Podcast: NRG2025 Phoenix Special Episode is Available Now!

The NRG Oncology Podcast co-hosts talk with Dr. Joan Walker and Dr. Jeff Michalski. Listen on Spotify | Apple Podcasts | YouTube | Amazon Music – Follow or Subscribe for new episodes.

2. NRG Oncology Currents newsletter

The January issue of the NRG Currents eNewsletter is now available. See this month's protocols in development, FORTE Study updates, Advocate Angle column and more! Click here to read more

3. Translational Science Committee Soliciting Pilot Projects for Inclusion in the NRG UG1 Translational Science Center Application

The NRG Oncology Translational Science Committee is soliciting one-page proposals (with Specific Aims) for pilot projects to incorporate into their “Network Group Integrated Translational Science Center” application due in February 2025. More information available here.

4. NRG Oncology Seeking Candidate for Deputy NCORP PI Role

We are seeking nominations for the position of Deputy NCORP PI. The NCI Community Oncology Research Program (NCORP) brings cancer research studies and results to patients in a variety of community settings across the United States. NRG is one of seven NCORP research bases and one of only four focused on adults with cancer. The focus of the NRG NCORP is on cancer control, cancer prevention and cancer care delivery. Patient reported outcomes and health disparities are cross-cutting themes incorporated into most NCORP protocols as well as NRG treatment trials. The deadline for the application submission is February 14, 2025. Read more

5. NRG Oncology Seeking Candidate for Cancer Control Committee Chair Role

We are seeking nominations for the position of Chair of the NRG NCORP Cancer Control Committee. Candidates for this position should have an active program of funded research and publications focused on the NRG cancer control priorities of improvement or delay in decline of neurocognitive function, reducing gender specific symptoms such as lymphedema and sexual function, and testing therapeutic delivery modifications to improve QoL and cost-effectiveness in localized cancers while maintaining efficacy. Candidates should have a track record of mentorship and a willingness to provide timely consultation to members and liaisons of NRG committees as concepts and protocols are being developed. In addition to leading the NRG Cancer Control Committee, this candidate will also serve as a co-chair of the Cancer Prevention and Control (CPC) Committee. This individual will work closely with the CPC on the priorities of the overall committee. The deadline for the application submission is February 14, 2025. Read more

6. AACR Special Conference in Cancer Research

The AACR Special Conference Meeting will be held January 26-29, 2025 in San Deigo. This is the first meeting focusing on radiation and targeted therapy. The program has many oral and poster presentation opportunities from proffered abstracts in addition to presentations from experts in the field. Register on the AACR website.

7. NRG Member Demographics Data Collection Initiative

We are excited to introduce the NRG Member Demographics Data Collection Initiative that will allow us to create a comprehensive member database, enabling us to better understand and serve our members. Your information will be kept secure and confidential, ensuring that your privacy is always protected. All members are encouraged to complete the form or indicate that they wish to opt out of this data collection initiative. 

Scan the QR code below or click this link to access the form. 

Questions? Read more here

NRG Oncology is pleased to report the following abstracts accepted for presentation at 2025 Annual Meeting for the American Society of Breast Surgeons.

ACCEPTED ABSTRACTS

Braunstein LZ, Mitchell MP, Bandos H, Sikov WM, Khan AJ, Chen PY, Ganz PA, Jagsi R, D P, White JR, Cecchini RS, Kang H, Puhalla SL, Gergelis K, Julian TB, Mamounas EP, Wolmark N. A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO): NRG-BR008. ASBrS (American Society of Breast Surgeons). 4/30/2025. Poster Presentation.

Wapnir IL, Cecchini RS, Li J, Anderson SJ, Julian TB, Boileau J, Mamounas EP, Dignam JJ, Wolmark N. Margin Width and Local Recurrence in the NRG Oncology/NSABP B-35 DCIS Lumpectomy Trial. ASBrS (American Society of Breast Surgeons). 4/30/2025. Oral Presentation.

Please note the following upcoming meetings and abstract submission deadlines

UPCOMING MEETINGS

American Association for Cancer Research (AACR); Apr 25-30, 2025; Chicago, IL

American Association for Thoracic Surgery (AATS); May 2-5, 2025; Seattle, WA

American Head & Neck Society (AHNS); May 14-15, 2025; New Orleans, LA

American Radium Society (ARS) Annual Meeting; Apr 3-6, 2025; Seattle, WA

American Society of Clinical Oncology (ASCO) GI; Jan 23-25, 2025; San Francisco, CA

American Society of Clinical Oncology (ASCO) GU; Feb 13-15, 2025; San Francisco, CA

American Surgical Association (ASA); Apr 24-26, 2025; San Diego, CA

European Society of Gynaecological Oncology (ESGO); Feb 20-23, 2025; Rome, Italy

Miami Breast Cancer Conference; Mar 6-9, 2025; Miami, FL

Society for Clinical Trials (SCT); May 18-21, 2025; Vancouver, BC

Society for Gynecologic Oncology (SGO); Mar 14-17, 2025; Seattle, WA

Society of Surgical Oncology (SSO) Annual Meeting; Mar 27-29, 2025; Tampa, FL

SSO – Advanced Cancer Therapies; Feb 14-17, 2025; Scottsdale, AZ

St. Gallen Breast Cancer Conference; Mar 12-15, 2025; Vienna Austria

UPCOMING ABSTRACT SUBMISSION DEADLINES

American Brachytherapy Society (ABS); Jun 18-21, 2025; Nashville, TN; Due to publications committee Jan 21, 2025; Submission deadline Feb 4, 2025, 6:00 pm PT

American College of Radiology (ACR); May 3-7, 2025; Washington, DC; Submission deadline Jan 27, 2025, 11:59 pm ET

American Society of Breast Surgeons (ASBrS); Apr 30-May 4, 2025; Las Vegas, NV; LBA Feb 5, 2025 (placeholder required)

American Society of Clinical Oncology (ASCO); May 30-Jun 3, 2025; Chicago, IL; Submission deadline Jan 28, 2025; LBA Mar 5, 2025 (placeholder required)

American Society of Colon and Rectal Surgeons (ASCRS); May 11-14, 2025; San Diego, CA; LBA and Clinical Trials Jan 29, 2025, 11:59 pm ET

American Society for Radiation Oncology (ASTRO); Sep 28-Oct 1, 2025; San Francisco, CA; Due to publications committee Feb 11, 2025; Submission deadline Feb 25, 2025, 11:59 pm PT; LBA Jul 10, 2025, 11:59 pm PT

Canadian Association of Radiation Oncology (CARO); Sep 10-13, 2025; Calgary, AB; Due to publications committee Feb 6, 2025; Submission deadline Feb 20, 2025

European Society for Medical Oncology (ESMO); Oct 17-21, 2025; Berlin, Germany; Due to publications committee Apr 25, 2025; Submission deadline May 13, 2025, 21:00 CET; LBA Sep 9, 2025, 21:00 CET (placeholder required)

ESMO Breast Cancer; May 14-16, 2025; Munich, Germany; Due to publications committee Jan 28, 2025; Submission deadline Feb 11, 2025, 21:00 CET; LBA Apr 15, 2025, 21:00 CET (placeholder required)

ESMO Gynaecological Cancers; Jun 19-21, 2025; Vienna, Austria; Due to publications committee Mar 18, 2025; Submission deadline Apr 1, 2025, 21:00 CET

European Society for Radiotherapy and Oncology (ESTRO); May 2-6, 2025; Vienna, Austria; LBA Mar 19, 2025



International Society for Quality-of-Life Research (ISOQOL); Oct 22-25, 2025; Milwaukee, WI; Due to publications committee Mar 25, 2025; Submission deadline Apr 7, 2025